Merck & Co., Inc., Rahway, NJ, USA (United States)
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Molecular Biology 7.7k
- Receptor Mechanisms and Signaling 889
- Chemical Synthesis and Analysis 878
- Protein purification and stability 656
- Top scholars
- Thomas A. HalgrenDavid E. MollerNancy A. ThornberryDonald W. NicholsonStephanie A. StudenskiWilliam K. HagmannBruce A. JohnsonGideon A. Rodan
- Journals
- Bioorganic & Medicinal Chemistry Letters (896 papers)Tetrahedron Letters (564 papers)Annals of Oncology (481 papers)Journal of Biological Chemistry (461 papers)Organic Process Research & Development (320 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Merck & Co., Inc., Rahway, NJ, USA (United States)
24.0k papers receiving 1.2M citations
Peers
Comparison fields: 5 of 249
- Oncology 196.0k
- Immunology 125.0k
- Molecular Biology 418.1k
- Pharmacology 84.6k
- Endocrinology, Diabetes and Metabolism 80.4k
Countries citing scholars working at Merck & Co., Inc., Rahway, NJ, USA (United States)
This map shows the geographic impact of research produced by authors working at Merck & Co., Inc., Rahway, NJ, USA (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Merck & Co., Inc., Rahway, NJ, USA (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merck & Co., Inc., Rahway, NJ, USA (United States) more than expected).
Fields of papers published by authors at Merck & Co., Inc., Rahway, NJ, USA (United States)
This network shows the impact of papers affiliated with Merck & Co., Inc., Rahway, NJ, USA (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Merck & Co., Inc., Rahway, NJ, USA (United States) at the time of their publication.
About Merck & Co., Inc., Rahway, NJ, USA (United States)
In recent decades, authors affiliated with Merck & Co., Inc., Rahway, NJ, USA (United States) have published 26.4k papers, which have received a total of 1.4M indexed citations . Scholars at this organization have produced 729 papers in Pharmaceutical Science, 7.7k papers in Molecular Biology, 1.8k papers in Pharmacology, 2.7k papers in Oncology and 1.7k papers in Infectious Diseases on the topics of Analytical Chemistry and Chromatography (988 papers), Receptor Mechanisms and Signaling (889 papers), Chemical Synthesis and Analysis (878 papers), Cancer Immunotherapy and Biomarkers (755 papers), Monoclonal and Polyclonal Antibodies Research (667 papers), Protein purification and stability (656 papers), Computational Drug Discovery Methods (636 papers) and Neuropeptides and Animal Physiology (620 papers). Their work is cited by papers focused on Oncology (196.0k citations), Immunology (125.0k citations), Molecular Biology (418.1k citations), Pharmacology (84.6k citations) and Endocrinology, Diabetes and Metabolism (80.4k citations). Authors at Merck & Co., Inc., Rahway, NJ, USA (United States) collaborate with scholars in United States, United Kingdom and Canada and have published in prestigious journals including Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Annals of Oncology, Journal of Biological Chemistry and Organic Process Research & Development. Some of Merck & Co., Inc., Rahway, NJ, USA (United States)'s most productive authors include Thomas A. Halgren, David E. Moller, Nancy A. Thornberry, Donald W. Nicholson, Stephanie A. Studenski, William K. Hagmann, Bruce A. Johnson, Gideon A. Rodan, William C. Campbell and Joel P. Berger.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.